The safety and efficacy of nintedanib for patients with progressive fibrosing interstitial lung disease in a real world setting-a prospective observational study
Latest Information Update: 14 Aug 2020
At a glance
- Drugs Nintedanib (Primary)
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- 14 Aug 2020 New trial record